Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Effect of schaftoside in inhibiting aspirin-induced gastric mucosal injury by targeting PYGB].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2026
Same author

Discovery of FYJ-195 as a Highly Potent FLT3 Inhibitor against Multiple Acquired Resistance Mutations in Acute Myeloid Leukemia.

Journal of medicinal chemistry·2026
Same author

Machine Learning Interpretability to Assess the Association Between Time in Tight Range and Mortality in Cardiogenic Shock.

Nursing in critical care·2026
Same author

Development and validation of the quiet quitting behavior scale: a mixed-methods study with primary healthcare workers in China.

Frontiers in public health·2026
Same author

Targeting tRNA-dependent tyrosine usage unveils a metabolic vulnerability in hepatocellular carcinoma.

Nature communications·2026
Same author

Lecithin supplementation to HFD improves largemouth bass liver health: Implications for regulating lipid homeostasis, antioxidant responses and endoplasmic reticulum stress.

Fish physiology and biochemistry·2026

Related Experiment Video

Updated: May 18, 2026

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

Solid lipid nanoparticles as delivery systems for Gambogenic acid.

Xia Huang1, Yan-Jie Chen, Dai-Yin Peng

  • 1Department of Clinical Pharmacy, Anhui University of Traditional Chinese Medicine, Hefei 230038, China.

Colloids and Surfaces. B, Biointerfaces
|September 27, 2012
PubMed
Summary

This study developed freeze-dried solid lipid nanoparticles (SLNs) loaded with Gambogenic acid (GNA-SLNs) to improve drug stability and efficacy. GNA-SLNs enhanced drug solubility and prolonged its half-life, showing potential for better therapeutic outcomes.

More Related Videos

Preparation and Characterization of Novel HDL-mimicking Nanoparticles for Nerve Growth Factor Encapsulation
08:24

Preparation and Characterization of Novel HDL-mimicking Nanoparticles for Nerve Growth Factor Encapsulation

Published on: May 22, 2017

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

Related Experiment Videos

Last Updated: May 18, 2026

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

Preparation and Characterization of Novel HDL-mimicking Nanoparticles for Nerve Growth Factor Encapsulation
08:24

Preparation and Characterization of Novel HDL-mimicking Nanoparticles for Nerve Growth Factor Encapsulation

Published on: May 22, 2017

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

Area of Science:

  • Pharmaceutical Nanotechnology
  • Drug Delivery Systems
  • Natural Product Chemistry

Background:

  • Gambogenic acid (GNA) exhibits therapeutic potential but suffers from poor aqueous solubility and toxicity.
  • Solid lipid nanoparticles (SLNs) offer a promising platform for improving drug delivery and bioavailability.
  • Developing stable and effective nanoformulations is crucial for enhancing the therapeutic index of GNA.

Purpose of the Study:

  • To formulate and characterize Gambogenic acid-loaded solid lipid nanoparticles (GNA-SLNs).
  • To evaluate the impact of freeze-drying on the stability and properties of GNA-SLNs.
  • To assess the in vitro release kinetics and in vivo pharmacokinetic profile of GNA-SLNs.

Main Methods:

  • GNA-SLNs were prepared using emulsification and low-temperature solidification, followed by freeze-drying.
  • Physical-chemical properties including particle size, zeta potential, morphology, and entrapment efficiency were analyzed.
  • In vitro drug release studies and pharmacokinetic evaluations in rats were conducted.

Main Results:

  • GNA-SLNs exhibited a mean particle size of 163.3 nm, a zeta potential of -16.9 mV, and an entrapment efficiency of 61.2%.
  • Freeze-drying slightly increased particle size and polydispersity index but maintained other properties, enhancing long-term stability.
  • In vitro release showed prolonged GNA release over 96 hours, and in vivo studies indicated a 3.1-fold increase in AUC and a 3.03-fold decrease in clearance.

Conclusions:

  • Freeze-dried GNA-SLNs offer enhanced long-term stability for SLN formulations.
  • SLN encapsulation is an effective strategy to overcome GNA's poor aqueous solubility and prolong its half-life.
  • This nanoformulation approach holds significant potential for improving GNA's therapeutic efficacy and reducing toxicity.